The global direct-to-consumer genetic testing market size was valued at USD 1.9 billion in 2023, driven by the rising number of global research and development activities. The market size is anticipated to grow at a CAGR of 20.7% during the forecast period of 2024-2032 to achieve a value of USD 10.4 billion by 2032.
Direct-to-consumer genetic tests allow consumers to access genetic testing without the direct involvement of healthcare providers. Direct-to-consumer genetic tests (DTC-GT) are genetic tests that are distributed directly to consumers to provide genetic information such as ancestry, health traits and health risks) with help of a saliva sample. These tests could be accurate and effective but still it is recommended to use health care professional’s advice to perform these tests.
The continuous technological innovations generating widespread interest from academics, clinicians, and consumers alike for consumer genetic testing has been driving the growth of the market. Polygenic score is the latest advancement in genomics which can potentially expand understandings of the scope and role of DTC genetic testing, which is expected to further propel the market growth. With Direct-to-consumer (DTC) genetic testing equipment there is no requirement for healthcare professionals to be around which is expected to reduce expenses and increase the availability to potential patients, further contributing to the direct-to-consumer genetic testing market growth.
The increasing health awareness among people is expanding the market significantly and this awareness has majorly been experienced in developed countries such as United States, Canada, and the United Kingdom. The rising prevalence of chronic diseases, including cancer, Alzheimer's disease, and Parkinson's disease are also driving the market growth. The increasing research and development on innovative genetic testing approaches are further expected to intensify the market growth.
Market Breakup by Test Type
Market Breakup by Technology
Market Breakup by Sales Channel
Market Breakup by End User
Market Breakup by Region
The increasing popularity of genetic testing among people and healthcare professionals are among major factors driving the market growth. The continuous advancements in technology are the reason that genealogy testing has become more accessible and affordable and this has directly increased its demand in the market. The pharmacogenetics has been witnessing significant traction recently and it is expected to expand the DTC testing space which will further increase the market growth. The increasing demand for precision and personalized medicine in clinics and increasing awareness about precision medicine is also expected to intensify the adoption of DTC genetic testing and increase the market demand. The high efficacy and accuracy of DTC genetic testing is also set to drive the market growth.
North America is leading the regional market and is expected to drive the market growth. The increased public awareness about direct-to-consumer genetic tests among regional population is a major factor responsible for market growth.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Test Type||
|Breakup by Technology||
|Breakup by Sales Channel||
|Breakup by End User||
|Breakup by Region||
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Direct-to-Consumer Genetic Testing Market Overview
3.1 Global Direct-to-Consumer Genetic Testing Market Historical Value (2017-2023)
3.2 Global Direct-to-Consumer Genetic Testing Market Forecast Value (2024-2032)
4 Global Direct-to-Consumer Genetic Testing Market Landscape
4.1 Global Direct-to-Consumer Genetic Testing Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Direct-to-Consumer Genetic Testing Product Landscape
4.2.1 Analysis by Test Type
4.2.2 Analysis by Technology
5 Global Direct-to-Consumer Genetic Testing Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Direct-to-Consumer Genetic Testing Market Segmentation
6.1 Global Direct-to-Consumer Genetic Testing Market by Test Type
6.1.1 Market Overview
6.1.2 Carrier Testing
6.1.3 Predictive Testing
6.1.4 Ancestry and Relationship Testing
6.1.5 Nutrigenomics Testing
6.2 Global Direct-to-Consumer Genetic Testing Market by Technology
6.2.1 Market Overview
6.2.2 Targeted Analysis
6.2.3 Single Nucleotide Polymorphism (SNP) Chips
6.2.4 Whole Genome Sequencing (WGS)
6.3 Global Direct-to-Consumer Genetic Testing Market by Sales Channel
6.3.1 Market Overview
6.3.2 Institutional Sales
184.108.40.206 Speciality Clinics
220.127.116.11 Diagnostic Laboratories
6.3.3 Retail Sales
18.104.22.168 Retail Pharmacies
22.214.171.124 Online sales
6.4 Global Direct-to-Consumer Genetic Testing Market by End User
6.4.2 Blood Banks
6.4.3 Nursing Homes
6.4.5 Imaging Centres
6.4.6 Home Care
6.5 Global Direct-to-Consumer Genetic Testing Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Direct-to-Consumer Genetic Testing Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Direct-to-Consumer Genetic Testing Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Direct-to-Consumer Genetic Testing Market
9.1 Market Share by Country
10 Latin America Direct-to-Consumer Genetic Testing Market
10.1 Market Share by Country
11 Middle East and Africa Direct-to-Consumer Genetic Testing Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
17 Supplier Landscape
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2 Gene by Gene
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.3 Easy DNA
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4 Karmagenes SA
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5 Living DNA Ltd.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 Helix OpCo LLC
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7 Full Genome Corporation Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8 Genesis Healthcare Co.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9 The SkinDNA Company Pty Ltd
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 DNA Genotek Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.11 DNA Diagnostic Center
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.12 Dante Lab
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.13 Ambry Genetics
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
18 Global Direct-to-Consumer Genetic Testing Market - Distribution Model (Additional Insight)
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 1.9 billion in 2023, driven by the continuous advancements in technology.
The market is anticipated to grow at a CAGR of 20.7% during the forecast period of 2024-2032, likely to reach a market value of USD 10.4 billion by 2032.
The increasing awareness of DTC genetic testing among people worldwide with expanded utilization of internet is a major factor driving the market growth.
The increasing focus of key players on developing high-quality DTC genetic testing products is a major trend influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Different types of direct-to-consumer genetic testing include carrier testing, predictive testing, ancestry and relationship testing, and nutrigenomics testing, among others.
There are various technologies used such as targeted analysis, single nucleotide polymorphism (SNP) chips, and whole genome sequencing (WGS).
The sales channels include institutional sales and retail sales.
End users in the market are laboratories, blood banks, nursing homes, hospitals, imaging centres, home care, and cosmetics, among others.
Key players involved in the market are Counsyl, Gene by Gene, Easy DNA, Karmagenes SA, Living DNA Ltd., Helix OpCo LLC, Full Genome Corporation Inc., Genesis Healthcare Co.
The SkinDNA Company Pty Ltd, DNA Genotek Inc., DNA Diagnostic Center, Dante Lab, and Ambry Genetics.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.